CA Stock MarketDetailed Quotes
RP RepliCel Life Sciences Inc
- 0.015
- 0.0000.00%
15min DelayPost Market Nov 5 16:00 ET
975.02KMarket Cap-750P/E (TTM)
0.000High0.000Low901Volume0.010Open0.015Pre Close9.01Turnover0.10052wk High0.00%Turnover Ratio65.00MShares0.01052wk Low-0.02EPS TTM475.47KFloat Cap9.900Historical HighLossP/E (Static)31.70MShs Float0.010Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-0.15P/B1Lot Size--Div YieldTTM
RepliCel Life Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00%88.43K | 0.00%88.43K | 0.00%88.43K | 0.00%353.74K | 0.00%88.43K | 0.00%88.43K | 0.00%88.43K | 0.00%88.43K | 0.00%353.74K | -0.00%88.43K |
| Operating revenue | 0.00%88.43K | 0.00%88.43K | 0.00%88.43K | 0.00%353.74K | 0.00%88.43K | 0.00%88.43K | 0.00%88.43K | 0.00%88.43K | 0.00%353.74K | -0.00%88.43K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 51.86%413.92K | -49.24%285.75K | 25.55%551.06K | -34.15%1.75M | -15.67%471.98K | -57.03%272.57K | -36.75%562.97K | -22.77%438.91K | 57.68%2.65M | 68.64%559.67K |
| Selling and administrative expenses | 285.90%372.37K | -51.75%209.16K | 10.04%377.09K | -25.27%1.13M | -22.77%252.59K | -74.28%96.49K | -17.07%433.52K | 22.00%342.68K | 70.21%1.51M | 88.01%327.06K |
| -General and administrative expense | 285.90%372.37K | -51.75%209.16K | 10.04%377.09K | -25.27%1.13M | -22.77%252.59K | -74.28%96.49K | -17.07%433.52K | 22.00%342.68K | 70.21%1.51M | 88.01%327.06K |
| Research and development costs | -76.40%41.55K | -39.32%79.41K | 78.18%173.97K | -45.70%623.96K | -5.19%219.39K | -32.03%176.08K | -64.64%130.86K | -66.17%97.64K | 40.24%1.15M | 28.53%231.39K |
| Other operating expenses | ---- | -100.00%-2.82K | ---- | 0.04%-2.82K | --0 | ---- | 50.00%-1.41K | -16.06%-1.41K | 87.25%-2.82K | --1.21K |
| Operating profit | -76.76%-325.48K | 58.42%-197.31K | -32.00%-462.63K | 39.41%-1.39M | 18.61%-383.55K | 66.26%-184.14K | 40.80%-474.53K | 26.96%-350.48K | -73.04%-2.3M | -93.57%-471.23K |
| Net non-operating interest income (expenses) | 0 | 0 | 148.40%726 | -21.96%-6.66K | 67.38%-1.8K | -3.27K | -88 | -2,273.91%-1.5K | -1,624.86%-5.46K | -5.53K |
| Non-operating interest income | --0 | --0 | 1,588.37%726 | -37.68%43 | --0 | --0 | --0 | -37.68%43 | -80.73%69 | --0 |
| Non-operating interest expense | --0 | --0 | --0 | 21.22%6.7K | -67.38%1.8K | --3.27K | --88 | --1.54K | --5.53K | --5.53K |
| Other net income (expenses) | 46.88%-493.12K | 41.27%-361.2K | -15.19%-501.47K | 137.08%656.12K | 845.64%2.66M | -219.82%-928.29K | -148.67%-615.03K | 50.28%-435.36K | -601.08%-1.77M | -3,063.12%-356.23K |
| Gain on sale of security | -67.84%-147.45K | 6.36%-52.04K | -578.74%-140.38K | 41.20%-545.09K | -5,364.80%-359.59K | -190.85%-87.86K | 33.31%-55.58K | 97.48%-20.68K | -401.97%-927.09K | 127.38%6.83K |
| Special income (charges) | ---- | ---- | ---95.79K | --0 | ---- | ---- | ---- | --0 | 3,792.13%31.14K | --0 |
| -Less:Other special charges | ---- | ---- | --95.79K | ---- | ---- | ---- | ---- | ---- | -3,792.13%-31.14K | --0 |
| Other non-operating income (expenses) | 58.87%-345.67K | 44.74%-309.15K | 36.02%-265.29K | 237.53%1.2M | 930.65%3.02M | -223.18%-840.44K | -186.72%-559.45K | -651.41%-414.67K | -1,175.32%-873.42K | -2,919.02%-363.06K |
| Income before tax | 26.63%-818.6K | 48.74%-558.51K | -22.36%-963.37K | 81.75%-743.23K | 372.61%2.27M | -33.44%-1.12M | -3.89%-1.09M | 41.91%-787.33K | -157.76%-4.07M | -227.04%-832.99K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 26.63%-818.6K | 49.76%-558.15K | -22.36%-963.37K | 81.75%-743.23K | 372.61%2.27M | -33.44%-1.12M | -5.92%-1.11M | 41.91%-787.33K | -157.76%-4.07M | -227.39%-832.99K |
| Net income continuous operations | 26.63%-818.6K | 49.76%-558.15K | -22.36%-963.37K | 81.75%-743.23K | 372.61%2.27M | -33.44%-1.12M | -5.92%-1.11M | 41.91%-787.33K | -157.76%-4.07M | -227.39%-832.99K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 26.63%-818.6K | 49.76%-558.15K | -22.36%-963.37K | 81.75%-743.23K | 372.61%2.27M | -33.44%-1.12M | -5.92%-1.11M | 41.91%-787.33K | -157.76%-4.07M | -227.39%-832.99K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 26.63%-818.6K | 49.76%-558.15K | -22.36%-963.37K | 81.75%-743.23K | 372.61%2.27M | -33.44%-1.12M | -5.92%-1.11M | 41.91%-787.33K | -157.76%-4.07M | -227.39%-832.99K |
| Diluted earnings per share | 66.67%-0.01 | 66.67%-0.01 | 50.00%-0.01 | 84.62%-0.02 | 200.00%0.03 | 0.00%-0.03 | 0.00%-0.03 | 50.00%-0.02 | -116.67%-0.13 | -200.00%-0.03 |
| Basic earnings per share | 66.67%-0.01 | 66.67%-0.01 | 50.00%-0.01 | 84.62%-0.02 | 200.00%0.03 | 0.00%-0.03 | 0.00%-0.03 | 50.00%-0.02 | -116.67%-0.13 | -200.00%-0.03 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data